IFP Advisors’s Filana Therapeutics FLNA Stock Holding History

IFP Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9	Hold	10	–	–	﹤0.01%	5176
2026 Q2	$12	Hold	10	–	–	﹤0.01%	5086
2026 Q1	$17	Hold	10	–	–	﹤0.01%	4938
2025 Q4	$20	Hold	10	–	–	﹤0.01%	4801
2025 Q3	$29	Hold	10	–	–	﹤0.01%	4724
2025 Q2	$18	Sell	10 -5	-33%	-$9	﹤0.01%	4854
2025 Q1	$23	Sell	15 -4	-21%	-$10	﹤0.01%	4148
2024 Q4	$126	Buy	19 +4	+27%	+$70	﹤0.01%	3947
2024 Q3	$441	Sell	15 -250	-94%	-$5.76K	﹤0.01%	3158
2024 Q2	$3.27K	Buy	265 +1	+0.4%	+$21	﹤0.01%	2697
2024 Q1	$5.36K	Sell	264 -200	-43%	-$4.61K	﹤0.01%	2437
2023 Q4	$10.4K	Sell	464 -8	-2%	-$169	﹤0.01%	2176
2023 Q3	$7.85K	Buy	472 +8	+2%	+$159	﹤0.01%	2346
2023 Q2	$11.4K	Hold	464	–	–	﹤0.01%	2252
2023 Q1	$571	Hold	464	–	–	﹤0.01%	3171
2022 Q4	$4K	Hold	464	–	–	﹤0.01%	3929
2022 Q3	$4K	Hold	464	–	–	﹤0.01%	4150
2022 Q2	$4K	Hold	464	–	–	﹤0.01%	3914
2022 Q1	$4K	Buy	464 +248	+115%	+$10.5K	﹤0.01%	3912
2021 Q4	$12K	Buy	216 +2	+0.9%	+$105	﹤0.01%	2162
2021 Q3	$14K	Buy	214 +13	+6%	+$1.08K	﹤0.01%	2144
2021 Q2	$17K	Buy	201 +1	+0.5%	+$54	﹤0.01%	2013
2021 Q1	$9K	Buy	+200	New	+$7.87K	﹤0.01%	2181

Other funds holding FLNA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

MGO One Seven Beachwood, Ohio $6.08B AUM 21.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

IFP Advisors's FLNA Position: Q3 2026 in Review

IFP Advisors held its Filana Therapeutics (FLNA) position steady in Q3 2026 at 10 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #5176.

IFP Advisors first reported a position in FLNA in Q1 2021 and has held it in 23 quarters since. The position peaked at $17K in Q2 2021. 34 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

IFP Advisors held 10 shares of Filana Therapeutics worth $9 as of Q3 2026.
IFP Advisors left its Filana Therapeutics share count unchanged in Q3 2026.
Filana Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5176 holding.
IFP Advisors first reported a position in Filana Therapeutics in Q1 2021 and has held it in 23 quarters since.
IFP Advisors's Filana Therapeutics position peaked at $17K in Q2 2021.
34 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.